Squarepoint’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-168,633
Closed -$2.12M 4233
2025
Q4
$2.12M Sell
168,633
-371,575
-69% -$4.25M ﹤0.01% 2016
2025
Q3
$5.41M Sell
540,208
-32,340
-6% -$290K 0.01% 1415
2025
Q2
$4.63M Buy
572,548
+420,398
+276% +$3.17M 0.01% 1513
2025
Q1
$1.28M Buy
152,150
+27,406
+22% +$229K ﹤0.01% 2454
2024
Q4
$988K Buy
124,744
+105,268
+541% +$883K ﹤0.01% 3081
2024
Q3
$162K Sell
19,476
-91,798
-82% -$718K ﹤0.01% 3760
2024
Q2
$707K Buy
+111,274
New +$706K ﹤0.01% 2812
2023
Q4
Sell
-31,020
Closed -$131K 3975
2023
Q3
$131K Buy
+31,020
New +$116K ﹤0.01% 3518
2023
Q2
Sell
-84,308
Closed -$117K 3529
2023
Q1
$117K Buy
84,308
+61,251
+266% +$122K ﹤0.01% 2941
2022
Q4
$45.9K Buy
+23,057
New +$51.7K ﹤0.01% 3066
2022
Q3
Sell
-55,303
Closed -$176K 2963
2022
Q2
$176K Sell
55,303
-35,305
-39% -$128K ﹤0.01% 2510
2022
Q1
$378K Buy
90,608
+38,321
+73% +$170K ﹤0.01% 2159
2021
Q4
$250K Sell
52,287
-3,039
-5% -$15.2K ﹤0.01% 2556
2021
Q3
$295K Sell
55,326
-19,273
-26% -$97K ﹤0.01% 2270
2021
Q2
$382K Buy
+74,599
New +$424K ﹤0.01% 2342
2021
Q1
Sell
-93,034
Closed -$425K 3071
2020
Q4
$425K Sell
93,034
-70,723
-43% -$313K ﹤0.01% 1930
2020
Q3
$635K Buy
163,757
+152,027
+1,296% +$650K 0.01% 1247
2020
Q2
$56K Sell
11,730
-26,707
-69% -$110K ﹤0.01% 2090
2020
Q1
$134K Sell
38,437
-364,471
-90% -$1.54M ﹤0.01% 1584
2019
Q4
$1.94M Sell
402,908
-7,095
-2% -$24.7K 0.01% 927
2019
Q3
$1.19M Buy
+410,003
New +$1.43M 0.01% 1107
2019
Q2
Sell
-286,808
Closed -$4.06M 2342
2019
Q1
$4.06M Buy
286,808
+216,251
+306% +$2.86M 0.04% 521
2018
Q4
$955K Buy
+70,557
New +$1.27M 0.01% 937

Other funds holding AMRX